82 related articles for article (PubMed ID: 20053517)
1. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
2. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS.
Kavitapu DR; Murty JNSRC; Maruthapillai A; Senadi GC; Mahapatra S
J Chromatogr Sci; 2024 Apr; 62(4):347-355. PubMed ID: 37340779
[TBL] [Abstract][Full Text] [Related]
3. Determination of stress-induced degradation products of cetirizine dihydrochloride by a stability-indicating RP-HPLC method.
Flórez Borges P; Pérez Lozano P; García Montoya E; Miñarro M; Ticó JR; Jo E; Suñe Negre JM
Daru; 2014 Dec; 22(1):82. PubMed ID: 25487685
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Related Substances of Ketoprofen and Omeprazole in Combined Capsule Dosage Form.
Koppala S; Reddy VR; Anireddy JS
J Chromatogr Sci; 2016; 54(5):765-75. PubMed ID: 26860397
[TBL] [Abstract][Full Text] [Related]
5. Eco-Friendly Stability-Indicating HPLC Method for Related Compounds in Pemetrexed Ditromethamine (Antineoplastic Agent) for Injection.
Nekkalapudi AR; Navuluri S; Pippalla S
J AOAC Int; 2024 May; 107(3):415-429. PubMed ID: 38310337
[TBL] [Abstract][Full Text] [Related]
6. Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.
Dannarm SR; Harini D; Reddy GN; Ali N; Sonti R
J Pharm Biomed Anal; 2024 Feb; 239():115909. PubMed ID: 38104374
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation.
Thummala VR; Tharlapu SS; Rekulapalli VK; Ivaturi MR; Nittala SR
Sci Pharm; 2014; 82(1):99-115. PubMed ID: 24634845
[TBL] [Abstract][Full Text] [Related]
8. A validated stability-indicating liquid chromatographic method for determination of process related impurities and degradation behavior of Irbesartan in solid oral dosage.
Goswami N
J Adv Pharm Technol Res; 2014 Jan; 5(1):33-40. PubMed ID: 24695518
[TBL] [Abstract][Full Text] [Related]
9. Development, Robustness by Design Expert and Validation of a Method for Enantiomeric Impurity Content Determination in Pretomanid Drug Substance and Pharmaceutical Dosage Form.
Surapuraju PKR; Juturu RR
J Chromatogr Sci; 2024 Apr; 62(4):311-320. PubMed ID: 36448313
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.
Raju TV; Seshadri RK; Arutla S; Mohan TS; Rao IM; Nittala SR
Sci Pharm; 2013; 81(1):123-38. PubMed ID: 23641333
[TBL] [Abstract][Full Text] [Related]
11. Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products.
Ali AM; Alanazi MM; Attwa MW; Darwish HW
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005198
[TBL] [Abstract][Full Text] [Related]
12. Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII.
Jadhav SB; Reddy PS; Narayanan KL; Bhosale PN
Sci Pharm; 2017 Jun; 85(3):. PubMed ID: 28653975
[TBL] [Abstract][Full Text] [Related]
13. Greens appraisal of validated stability indicating RP-HPLC method and forced degradation study for quantification of Ebastine in wastewater and dosage form.
Almalki MA; Alanazi TYA; Mahgoub SM; Abo El-Ela FI; Mohamed MA
Ann Pharm Fr; 2024 May; 82(3):420-432. PubMed ID: 37739216
[TBL] [Abstract][Full Text] [Related]
14. Stability-indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC.
Nagulancha BR; Vandavasi KR
Biomed Chromatogr; 2023 Nov; 37(11):e5727. PubMed ID: 37635093
[TBL] [Abstract][Full Text] [Related]
15. Structural Elucidation of Novel Degradation Impurity and Development, Validation of a Single HPLC Method for all Putative Impurities of Clobetasol Propionate in a Foam Drug Product.
Ketha NVDP; Kolli D; Subbappa PK
J Chromatogr Sci; 2024 May; 62(5):444-453. PubMed ID: 36857571
[TBL] [Abstract][Full Text] [Related]
16. Investigation of aclidinium bromide degradation by stability-indicating HPLC methods, characterization of impurities by NMR, and identification of degradation products by LC-MS.
Yazar Y; Aydın Özel FG; Bellur Atici E; Yılmaz E; Narin İ
J Pharm Biomed Anal; 2024 Jan; 238():115845. PubMed ID: 37948775
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Stress Testing Characteristics of Apixaban, Structural Elucidation of a Novel Degradation Impurity, and Stability-Indicating Method Development for Quantification of Related Substances.
Surukonti SR; Surendrababu MS
J AOAC Int; 2024 Jan; 107(1):22-30. PubMed ID: 37698982
[TBL] [Abstract][Full Text] [Related]
18. Stability-Indicating HPLC Method for Determination of Ibuprofen and Famotidine Degradation Products.
Atilgan N; Tabansiz G; Turkes E; Sarracoglu N; Doganay AA; Pinarbasli O
J Chromatogr Sci; 2024 May; ():. PubMed ID: 38727201
[TBL] [Abstract][Full Text] [Related]
19. Delineation of prototypical degradation mechanism, characterization of unknown degradation impurities by liquid chromatography-quadrupole-time-of-flight-tandem mass spectrometry and stability-indicating analytical method of selumetinib.
Mishra S; Rajput N; Jadav T; Panday NK; Sahu AK; Sengupta P
Biomed Chromatogr; 2024 Jan; 38(1):e5761. PubMed ID: 37920143
[TBL] [Abstract][Full Text] [Related]
20. Identification of Forced Degradation Products of Itopride by LC-PDA and LC-MS.
Joshi P; Bhoir S; Bhagwat AM; Vishwanath K; Jadhav RK
Indian J Pharm Sci; 2011 May; 73(3):287-91. PubMed ID: 22457552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
